• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯硫烷基胺在小鼠实验性肿瘤治疗中的应用

Phenylthioalkylamines in experimental tumor treatment in mice.

作者信息

DiStefano V, Evans I, Myers-Robfogel M, Estes J, Godleski S A

出版信息

J Natl Cancer Inst. 1983 Dec;71(6):1289-93.

PMID:6581362
Abstract

Two phenylthioalkylamines, phenylthioethylamine (PTEA) and phenylthiopropylamine (PTPA), were prepared and tested for cytotoxicity in vitro and as antitumor agents in (C57BL X DBA/2)F1 (BDF1) mice. Low concentrations of PTEA (median effective concentrations of 8.0, 12.0, and 1.3 micrograms PTEA/ml) inhibited the growth of P388 murine lymphoma, L1210 leukemia, and B16 melanoma cells in culture. PTPA was more effective; concentrations of 0.80, 0.56, and 0.35 micrograms PTPA/ml inhibited the growth of P388, L1210, and B16 in vitro by 50%. PTEA and PTPA treatment increased survival times in BDF1 mice bearing the P388 lymphoma, L1210 leukemia, B16 melanoma, and Lewis lung tumors. Multiple daily administrations of the test compounds were more effective than single daily injections in increasing the life-span in mice bearing the P388 lymphoma and B16 melanoma. Both PTEA and PTPA inhibited the enzyme copper-zinc superoxide dismutase.

摘要

制备了两种苯硫基烷基胺,苯硫基乙胺(PTEA)和苯硫基丙胺(PTPA),并对其进行体外细胞毒性测试以及作为抗肿瘤剂在(C57BL×DBA/2)F1(BDF1)小鼠体内进行测试。低浓度的PTEA(中位有效浓度分别为8.0、12.0和1.3微克PTEA/毫升)在培养中抑制了P388鼠淋巴瘤、L1210白血病和B16黑色素瘤细胞的生长。PTPA更有效;0.80、0.56和0.35微克PTPA/毫升的浓度在体外使P388、L1210和B16的生长受到50%的抑制。PTEA和PTPA处理延长了携带P388淋巴瘤、L1210白血病、B16黑色素瘤和Lewis肺癌的BDF1小鼠的存活时间。在延长携带P388淋巴瘤和B16黑色素瘤小鼠的寿命方面,每日多次给药比每日单次注射更有效。PTEA和PTPA均抑制了铜锌超氧化物歧化酶。

相似文献

1
Phenylthioalkylamines in experimental tumor treatment in mice.苯硫烷基胺在小鼠实验性肿瘤治疗中的应用
J Natl Cancer Inst. 1983 Dec;71(6):1289-93.
2
Antitumor activity of macromomycin B (NSC 170105) against murine leukemias, melanoma, and lung carcinoma.大分子霉素B(NSC 170105)对小鼠白血病、黑色素瘤和肺癌的抗肿瘤活性。
Cancer Res. 1975 Apr;35(4):939-45.
3
Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.两种新合成的亚硝基脲糖的治疗和致糖尿病潜力。
Cancer Res. 1985 Feb;45(2):695-702.
4
Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.嘧啶酮类化合物治疗B16黑色素瘤和P388白血病的抗肿瘤作用机制
Cancer Res. 1985 Feb;45(2):532-8.
5
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.新型蒽基双腙9,10-蒽二甲醛双[(4,5-二氢-1H-咪唑-2-基)腙]二盐酸盐对小鼠实验性肿瘤的活性
Cancer Res. 1982 Feb;42(2):440-4.
6
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.新型双腙桥联4-去甲氧基柔红霉素衍生物SC33428对小鼠实验性肿瘤的活性
Cancer Res. 1983 Jun;43(6):2880-3.
7
Psychotropic drugs as potential antitumor agents: a selective screening study.精神药物作为潜在的抗肿瘤药物:一项选择性筛选研究。
Cancer Treat Rep. 1978 Jan;62(1):45-74.
8
Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.偕胺肟(羟基脲类似物)在小鼠肿瘤系统中的抗肿瘤活性。
Cancer Res. 1978 May;38(5):1291-5.
9
Biological activity of 1,4-dihydropyridine derivatives.1,4 - 二氢吡啶衍生物的生物活性
Arch Immunol Ther Exp (Warsz). 1985;33(2):345-52.
10
4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.4'-O-四氢吡喃基阿霉素作为一种潜在的新型抗肿瘤药物。
Cancer Res. 1982 Apr;42(4):1462-7.